Settlements and judgements under the False Claims Act (FCA) surpassed $2.2 billion for the fiscal year ending Sept. 30, 2022. Of that, $1.7 billion related to matters involving the healthcare industry, including drug and medical device manufacturers, durable medical equipment, home health and managed care providers, hospitals, pharmacies, hospice organizations, and physicians. The government and…

Read More

A Texas physician faces significant time behind bars after being convicted of engaging in a scheme to fraudulently bill TRICARE, for toxicology and genetic tests that were not provided as represented and/or were medically unnecessary. TRICARE is the healthcare program for uniformed service members, retirees, and their families,  Dr. Sekhar Rao, a vascular and interventional…

Read More

The U.S. Department of Justice, through coordinated investigations across 13 districts, has filed criminal charges against three dozen defendants who allegedly were involved in $1.2 billion in fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment schemes. Those charged include a telemedicine company executive, owners and executives of clinical laboratories, durable medical equipment…

Read More

The Department of Health and Human Services Office of the Inspector General (HHS-OIG) expects to make nearly $3 billion in recoveries resulting from the agency’s audits and investigations, according to its Semiannual Report to Congress released earlier this month. The semiannual reporting period runs from Oct. 1, 2021, through March 31, 2022. The watchdog agency…

Read More

The Covid-19 pandemic has resulted in yet another avenue to perpetuate fraud within the healthcare arena. Most recently, the U.S. Department of Justice announced criminal charges had been filed against 21 people in nine federal districts for their alleged participation in various schemes that exploited the pandemic to the tune of $149 million. Cities involved…

Read More